Tak Paul Peter - Insider Non-Derivative Transactions at Candel Therapeutics, Inc. (CADL) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 25, 2025, Tak Paul Peter's relationship to Candel Therapeutics, Inc. (CADL) is Director,Officer (Chief Executive Officer), and currently has 268,566 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CADL insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Tak Paul Peter - Insider Non-Derivative Transactions of CADL Common Stock

Tak Paul Peter - Insider Non-Derivative Transactions at CADL

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 26, 2025	Acquisition -- (Common Stock)	42826	4.67	268566
Mar 20, 2025	Sell -- (Common Stock)	400	9	225740
Mar 19, 2025	Sell -- (Common Stock)	25772	8.77	226140
Jan 16, 2025	Sell -- (Common Stock)	21704	7.23	251912
Jan 9, 2025	Sell -- (Common Stock)	21172	8.22	273616
Nov 30, 2024	Sell -- (Common Stock)	48847	4.56	294788
Nov 22, 2024	M -- (Common Stock)	12900	1.55	343635
Jul 18, 2024	Sell -- (Common Stock)	22528	6.47	330735
Jul 12, 2024	Sell -- (Common Stock)	20293	5.97	353263
Nov 29, 2023	F -- (Common Stock)	43443	0.9	373556
Nov 27, 2023	Acquisition -- (Common Stock)	180108	0	416999